Indeed, HER2 expression seems to be non-uniform in some breast tumours due to the co-existence of multiple cancer cell subpopulations in the same tumour area or in different areas of a single tumour, and so lead to discrepant HER2 status results, depending on the analysed region [33]. The gene discussed is ERBB2; the disease is breast neoplasm.